375E Clinical development of the HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) etravirine for the pediatric population

Saturday, April 25, 2009
Thomas N. Kakuda, Pharm.D. , Tibotec Inc., Yardley, PA
Rekha Sinha, M.D. , Tibotec BVBA, Mechelen, Belgium
Ingeborg Peeters, B.S. , Tibotec BVBA, Mechelen, Belgium
Rebecca Mack, M.S. , Tibotec Inc., Yardley, PA
Katrien Janssen, M.S. , Tibotec BVBA, Mechelen, Belgium
Aleidis Lasure, Pharm.D. , Tibotec BVBA, Mechelen, Belgium
Katia Boven, M.D. , Tibotec Inc., Yardley, PA
Richard M. W. Hoetelmans, Pharm.D., Ph.D. , Tibotec BVBA, Mechelen, Belgium